• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较 CAT 与 mMRC 对 COPD 患者特征的影响:一项回顾性、横断面研究。

Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.

机构信息

Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.

Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan.

出版信息

NPJ Prim Care Respir Med. 2015 Nov 5;25:15063. doi: 10.1038/npjpcrm.2015.63.

DOI:10.1038/npjpcrm.2015.63
PMID:26538368
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4633725/
Abstract

BACKGROUND

The group assignment of chronic obstructive pulmonary disease (COPD) may differ depending on whether the COPD assessment test (CAT) or modified Medical Research Council dyspnoea scale (mMRC) is used.

AIMS

This study intended to clarify how different patient characteristics influence the differences, to determine the relationships between CAT and mMRC and to characterise COPD patients by both CAT and mMRC.

METHODS

This was a retrospective, cross-sectional study. The data, collected by Taiwan Obstructive Lung Disease consortium, were managed and analysed.

RESULTS

Of the 757 participants, COPD group assignment was not identical as well as no substantial agreement presented when categorised based on the cut-point CAT score ⩾10 and each mMRC cut-point. In all, 38.2% of participants had discordant group assignments together with a lower mean CAT score, less severe airway obstruction and less severe airflow limitation compared with those with concordant group assignments. In the discordant group, the CAT⩾10/mMRC 0-1 subgroup had more wheezing than CAT<10/mMRC⩾2 subgroup. Only moderate correlations existed between CAT and mMRC. More-symptom groups and combined high-risk group had better correlations than less-symptom groups and combined low-risk group, respectively. A modest negative correlation existed between forced expiratory volume in 1 s percentage (FEV1%) predicted and CAT score and between FEV1% predicted and mMRC scale in parallel with a significant positive relationship existing between the CAT score and mMRC scale. Notably, a significant proportion of COPD patients with each scale of mMRC had health status impairment.

CONCLUSIONS

The Global initiative for Chronic Obstructive Lung Disease committee should redefine the applications of CAT and mMRC in the management of COPD.

摘要

背景

慢性阻塞性肺疾病(COPD)的分组可能因使用 COPD 评估测试(CAT)或改良的医学研究理事会呼吸困难量表(mMRC)而有所不同。

目的

本研究旨在阐明不同的患者特征如何影响差异,确定 CAT 和 mMRC 之间的关系,并通过 CAT 和 mMRC 来描述 COPD 患者的特征。

方法

这是一项回顾性、横断面研究。数据由台湾阻塞性肺病联盟收集和管理,并进行分析。

结果

在 757 名参与者中,根据 CAT 评分≥10 和每个 mMRC 切点分类时,COPD 分组不一致,也没有实质性的一致性。总体而言,38.2%的参与者分组不一致,他们的 CAT 评分较低,气道阻塞程度较轻,气流受限程度较轻。在不一致的分组中,CAT≥10/mMRC 0-1 亚组比 CAT<10/mMRC≥2 亚组更常出现喘息。CAT 与 mMRC 之间仅存在中度相关性。症状较多的组和联合高危组的相关性优于症状较少的组和联合低危组。FEV1%预计值与 CAT 评分之间存在适度的负相关,与 mMRC 量表之间存在显著的正相关。FEV1%预计值与 CAT 评分之间存在显著的正相关。值得注意的是,相当比例的 COPD 患者在每个 mMRC 量表上都存在健康状况受损。

结论

全球慢性阻塞性肺疾病倡议委员会应重新定义 CAT 和 mMRC 在 COPD 管理中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41f2/4633725/49df06a9a34c/npjpcrm201563-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41f2/4633725/e569a1bfb04e/npjpcrm201563-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41f2/4633725/49df06a9a34c/npjpcrm201563-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41f2/4633725/e569a1bfb04e/npjpcrm201563-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41f2/4633725/49df06a9a34c/npjpcrm201563-f2.jpg

相似文献

1
Features of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional study.比较 CAT 与 mMRC 对 COPD 患者特征的影响:一项回顾性、横断面研究。
NPJ Prim Care Respir Med. 2015 Nov 5;25:15063. doi: 10.1038/npjpcrm.2015.63.
2
Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.使用 COPD 评估测试 (CAT) 或改良版医学研究理事会呼吸困难评分 (mMRC) 对 COPD 组进行分类的差异:一项横断面分析。
BMC Pulm Med. 2013 Jun 3;13:35. doi: 10.1186/1471-2466-13-35.
3
Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.COPD 评估测试(CAT)与改良版医学研究理事会呼吸困难量表(mMRC)在 COPD 患者临床症状、合并症及医疗资源利用评估方面的比较。
J Formos Med Assoc. 2019 Jan;118(1 Pt 3):429-435. doi: 10.1016/j.jfma.2018.06.018. Epub 2018 Aug 25.
4
GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.慢性阻塞性肺疾病的GOLD分类:症状与急性加重风险评估标准中的不一致性
COPD. 2017 Feb;14(1):1-6. doi: 10.1080/15412555.2016.1230844. Epub 2016 Oct 10.
5
Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.慢性阻塞性肺疾病(COPD)患者改良医学研究委员会呼吸困难评分与COPD评估测试评分之间的差异
Int J Chron Obstruct Pulmon Dis. 2015 Aug 12;10:1623-31. doi: 10.2147/COPD.S87147. eCollection 2015.
6
Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification.COPD 患者健康状况评分与 MRC 分级的比较:对 GOLD 2011 分类的影响。
Eur Respir J. 2013 Sep;42(3):647-54. doi: 10.1183/09031936.00125612. Epub 2012 Dec 20.
7
Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.慢性阻塞性肺疾病全球倡议策略分类的真实世界特征与区分
Int J Chron Obstruct Pulmon Dis. 2014 May 28;9:551-61. doi: 10.2147/COPD.S62104. eCollection 2014.
8
Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.改良医学研究委员会量表与基线呼吸困难指数用于评估慢性阻塞性肺疾病中的呼吸困难
Int J Chron Obstruct Pulmon Dis. 2015 Aug 18;10:1663-72. doi: 10.2147/COPD.S82408. eCollection 2015.
9
[Correlation between pulmonary quantitative CT measurement indicators and respiratory symptoms in patients with chronic obstructive pulmonary disease in stable stage].[稳定期慢性阻塞性肺疾病患者肺部CT定量测量指标与呼吸症状的相关性]
Zhonghua Yi Xue Za Zhi. 2023 Oct 17;103(38):3017-3025. doi: 10.3760/cma.j.cn112137-20230418-00627.
10
COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV - a post-hoc analysis of pooled data.基于支气管扩张剂后 FEV1 的 COPD 加重和患者报告结局 - 汇总数据的事后分析。
BMC Pulm Med. 2023 Apr 28;23(1):150. doi: 10.1186/s12890-023-02436-1.

引用本文的文献

1
Quantitative chest computed tomography in chronic obstructive pulmonary disease: assessing the role of emphysema severity and its correlation with clinical characteristics, lung function, and plasma levels of VEGF and IL-1β.慢性阻塞性肺疾病的胸部定量计算机断层扫描:评估肺气肿严重程度的作用及其与临床特征、肺功能以及血管内皮生长因子(VEGF)和白细胞介素-1β(IL-1β)血浆水平的相关性
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251332469. doi: 10.1177/17534666251332469. Epub 2025 Apr 29.
2
T-cell immune status in patients with acute exacerbation of chronic obstructive pulmonary disease: a case-control study.慢性阻塞性肺疾病急性加重患者的T细胞免疫状态:一项病例对照研究。
Front Med (Lausanne). 2025 Jan 24;12:1433844. doi: 10.3389/fmed.2025.1433844. eCollection 2025.
3

本文引用的文献

1
Little agreement in GOLD category using CAT and mMRC in 450 primary care COPD patients in New Zealand.在新西兰450例初级保健慢性阻塞性肺疾病(COPD)患者中,使用慢性阻塞性肺疾病评估测试(CAT)和改良英国医学研究委员会(mMRC)呼吸困难量表进行慢性阻塞性肺疾病全球倡议(GOLD)分级时,一致性较差。
NPJ Prim Care Respir Med. 2014 Jul 24;24:14025. doi: 10.1038/npjpcrm.2014.25.
2
Real-world characterization and differentiation of the Global Initiative for Chronic Obstructive Lung Disease strategy classification.慢性阻塞性肺疾病全球倡议策略分类的真实世界特征与区分
Int J Chron Obstruct Pulmon Dis. 2014 May 28;9:551-61. doi: 10.2147/COPD.S62104. eCollection 2014.
3
Association between impairment of lung function and risk of anxiety and depression in patients with chronic obstructive pulmonary disease-a systematic review.慢性阻塞性肺疾病患者肺功能损害与焦虑和抑郁风险之间的关联——一项系统综述
Syst Rev. 2024 Dec 4;13(1):300. doi: 10.1186/s13643-024-02720-z.
4
Application of standardized management and effect evaluation of chronic obstructive pulmonary disease patients using the big data center of the Internet of Things.基于物联网大数据中心的慢性阻塞性肺疾病患者标准化管理及效果评估应用
Digit Health. 2024 Mar 15;10:20552076241237706. doi: 10.1177/20552076241237706. eCollection 2024 Jan-Dec.
5
Spirometric Interpretation and Clinical Relevance According to Different Reference Equations.根据不同的参考方程进行肺量计解读和临床相关性评估。
J Korean Med Sci. 2024 Jan 29;39(4):e20. doi: 10.3346/jkms.2024.39.e20.
6
Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy.队列研究评估特发性肺纤维化患者接受氧疗的预后因素。
Sci Rep. 2023 Aug 22;13(1):13664. doi: 10.1038/s41598-023-40508-8.
7
COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV - a post-hoc analysis of pooled data.基于支气管扩张剂后 FEV1 的 COPD 加重和患者报告结局 - 汇总数据的事后分析。
BMC Pulm Med. 2023 Apr 28;23(1):150. doi: 10.1186/s12890-023-02436-1.
8
How to Utilize CAT and mMRC Scores to Assess Symptom Status of Patients with COPD in Clinical Practice?如何在临床实践中利用CAT和mMRC评分评估慢性阻塞性肺疾病患者的症状状态?
Medeni Med J. 2022 Jun 23;37(2):173-179. doi: 10.4274/MMJ.galenos.2022.06787.
9
Herbal Medicines for the Treatment of Chronic Obstructive Airway Diseases (Asthma or Chronic Obstructive Pulmonary Disease): A Prospective Observational Study.用于治疗慢性阻塞性气道疾病(哮喘或慢性阻塞性肺疾病)的草药:一项前瞻性观察研究。
Evid Based Complement Alternat Med. 2022 May 29;2022:3485757. doi: 10.1155/2022/3485757. eCollection 2022.
10
Immunophenotype in acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study.慢性阻塞性肺疾病急性加重期的免疫表型:一项横断面研究。
Respir Res. 2022 May 28;23(1):137. doi: 10.1186/s12931-022-02058-x.
Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
非吸烟慢性阻塞性肺疾病患者与吸烟慢性阻塞性肺疾病患者的临床特征比较:一项回顾性观察研究。
Int J Chron Obstruct Pulmon Dis. 2014;9:57-63. doi: 10.2147/COPD.S52416. Epub 2014 Jan 8.
4
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.COPDGene 研究中的 GOLD 2011 疾病严重程度分类:一项前瞻性队列研究。
Lancet Respir Med. 2013 Mar;1(1):43-50. doi: 10.1016/S2213-2600(12)70044-9. Epub 2012 Sep 3.
5
Classification of chronic obstructive pulmonary disease severity according to the new Global Initiative for Chronic Obstructive Lung Disease 2011 guidelines: COPD assessment test versus modified Medical Research Council scale.根据新的全球慢性阻塞性肺疾病倡议 2011 年指南对慢性阻塞性肺疾病严重程度的分类:COPD 评估测试与改良版医学研究委员会量表。
Arch Bronconeumol. 2014 Apr;50(4):129-34. doi: 10.1016/j.arbres.2013.09.014. Epub 2013 Nov 21.
6
Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial.在 POET-COPD 试验中对加重风险和加重表型的特征描述。
Respir Res. 2013 Oct 29;14(1):116. doi: 10.1186/1465-9921-14-116.
7
Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.使用 COPD 评估测试 (CAT) 或改良版医学研究理事会呼吸困难评分 (mMRC) 对 COPD 组进行分类的差异:一项横断面分析。
BMC Pulm Med. 2013 Jun 3;13:35. doi: 10.1186/1471-2466-13-35.
8
Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification.COPD 患者健康状况评分与 MRC 分级的比较:对 GOLD 2011 分类的影响。
Eur Respir J. 2013 Sep;42(3):647-54. doi: 10.1183/09031936.00125612. Epub 2012 Dec 20.
9
Properties of the COPD assessment test in a cross-sectional European study.COPD 评估测试在一项欧洲横断面研究中的特性。
Eur Respir J. 2011 Jul;38(1):29-35. doi: 10.1183/09031936.00177210. Epub 2011 May 12.
10
Lung function impairment, COPD hospitalisations and subsequent mortality.肺功能损害、COPD 住院治疗和随后的死亡率。
Thorax. 2011 Jul;66(7):585-90. doi: 10.1136/thx.2010.152876. Epub 2011 Apr 22.